ARTICLE | Company News
DiagnoCure, Compugen diagnostics deal
January 14, 2002 8:00 AM UTC
Molecular testing company DiagnoCure (TSE:CUR) and bioinformatics play CGEN said they would develop and commercialize molecular diagnostic tests to detect certain epithelial cancers including lung can...